Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00386659
Status:
TERMINATED
Last Update Posted:
2006-10-11
First Post:
2006-10-10
Brief Title:
Immune Reconstitution in naïve HIV Patients With CD4 100 CellsmL When Treated With Lopinavir or Efavirenz
Sponsor:
Hospital Clinic of Barcelona
Organization:
Hospital Clinic of Barcelona
Study Overview
Official Title:
A Randomized Pilot Study on the Antiviral Activity and Immunological Effects of LopinavirRitonavir vs Efavirenz in Treatment-naïve HIV-Infected Patients With CD4 Cell Counts Below 100 Cellsmm3
Status:
TERMINATED
Status Verified Date:
2006-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Pilot randomized parallel open-label controlled clinical study evaluating virological response in plasma and extra-plasmatic compartments together with the degree and kinetics of immune reconstitution in treatment-naïve patients with CD4 count below 100 cellsmL when treated with tenofovir and abacavir together with lopinavir or efavirenz
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None